Withdrawals due to adverse events · adults with SAnD
It is very uncertain whether comparison 5: benzodiazepines changes dropouts due to adverse events (acute phase) compared with placebo (very low certainty).
1 finding from 1 review
Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS total score · adults with SAnD
1 finding from 1 review
Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD
1 finding from 1 review
Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS fear subscale · adults with SAnD
1 finding from 1 review
Recurrence of any episodes at one year for clinical worsening with additional psychotropics (mood stabilizers, antidepressants, antipsychotics or benzodiazepines) · bipolar disorder
Lamotrigine showed no clear difference in recurrence of any episodes at one year for clinical worsening with… compared with lithium (moderate certainty).
1 finding from 1 review
Recurrence of any episodes at one year for clinical worsening with additional psychotropics (mood stabilizers, antidepressants, antipsychotics or benzodiazepines) · bipolar disorder
Lamotrigine probably leads to lower recurrence of any episodes at one year for clinical worsening with… compared with placebo (moderate certainty).
1 finding from 1 review
Failure to respond at endpoint (6‐12 weeks) · adults with panic disorder
Antidepressants showed no clear difference in failure to respond compared with benzodiazepines (low certainty).
1 finding from 1 review
panic symptoms · adults with panic disorder
2 findings from 1 review
Withdrawals due to adverse events · adults with panic disorder
TCAs may leads to higher number of dropouts due to adverse effects compared with benzodiazepines (low certainty).
1 finding from 1 review
Failure to respond at endpoint (6‐12 weeks) · adults with panic disorder
It is very uncertain whether SSRIs changes failure to respond compared with benzodiazepines (very low certainty).
1 finding from 1 review
Leaving the study early · adults with panic disorder
It is very uncertain whether SSRIs changes total number of dropouts compared with benzodiazepines (very low certainty).
1 finding from 1 review
Failure to remit at endpoint · adults with panic disorder
It is very uncertain whether SSRIs changes failure to remit compared with benzodiazepines (very low certainty).
1 finding from 1 review
panic symptoms · adults with panic disorder
1 finding from 1 review
Withdrawals due to adverse events · adults with panic disorder
It is very uncertain whether SSRIs changes number of dropouts due to adverse effects compared with benzodiazepines (very low certainty).
1 finding from 1 review
Leaving the study early · adults with panic disorder
It is very uncertain whether antidepressants changes total number of dropouts compared with benzodiazepines (very low certainty).
1 finding from 1 review
Failure to remit at endpoint · adults with panic disorder
Antidepressants probably leads to higher failure to remit compared with benzodiazepines (moderate certainty).
1 finding from 1 review
panic symptoms · adults with panic disorder
2 findings from 1 review
Withdrawals due to adverse events · adults with panic disorder
Antidepressants may leads to higher number of dropouts due to adverse effects compared with benzodiazepines (low certainty).
1 finding from 1 review
Failure to respond at endpoint (6‐12 weeks) · adults with panic disorder
It is very uncertain whether TCAs changes failure to respond compared with benzodiazepines (very low certainty).
1 finding from 1 review
Leaving the study early · adults with panic disorder
It is very uncertain whether TCAs changes total number of dropouts compared with benzodiazepines (very low certainty).
1 finding from 1 review